Remove Leads Remove Safety Remove Side effects Remove Training
article thumbnail

How to Boost Pharma Sales AI Training with AI Insights

Quantified

In response, forward-thinking corporate decision-makers nationwide are turning to cutting-edge pharma sales AI training to optimize the impact of every human interaction. AI-supported training platforms offering life-like detailing simulations, on the other hand, are designed to assess human interactions objectively.

article thumbnail

Leading speciality pharmacies in pharma

Pharmaceutical Technology

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. Patient education and medication adverse effect counselling. Patient monitoring for safety and efficacy. The post Leading speciality pharmacies in pharma appeared first on Pharmaceutical Technology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Artificial Intelligence Could Be the Ultimate Weapon Against Cancer

MedCity News

With the rise of AI technologies, we could see significant advancements in cancer treatment, making it more efficient and potentially leading to a cure. By analyzing vast amounts of data from medical records, laboratory tests and imaging scans, AI algorithms can provide a more precise diagnosis, which can lead to better treatment outcomes.

article thumbnail

Tributes as former NICE, MHRA chair Sir Mike Rawlins dies

pharmaphorum

A pharmacologist by training, Rawlins was the founding chairman of health technology assessment (HTA) agency NICE , leading the organisation from its inception in 1999 until 2013, and hired Sir Andrew Dillon to become the organisation’s founding chief executive.

article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

Over the past few years, we have researched the types of evidence used in regulatory decisions for drug product withdrawals due to safety concerns in Europe. But from a safety point of view, observational studies can be more representative of the population the drug will serve. Lane S, Lynn E, Shakir S.

Safety 109
article thumbnail

Developing a first-in-class small molecule drug for inflammatory disease

European Pharmaceutical Review

Positively, Brager shared that in clinical trials , the company’s lead clinical candidate has demonstrated ability to cross the blood-brain barrier and to “not cause serious side effects common with traditional immunosuppressive therapies that treat inflammation.” This allows us to stay on top of quality control.

article thumbnail

Streamlining healthcare with AI for drug development

Pharmaceutical Technology

Developing safe and effective drugs Pharma researchers are using AI in the earliest stages. They’re also deploying AI to predict how new drugs will interact with the human body — and what side effects might arise. AI’s ability to analyze data quickly also contributes to safety, including during clinical trials.